IRIS Soft Celebrates Its 10th Anniversary!
This year, our company IRIS Soft (Institute for Information Systems Development) is celebrating 10 years of its activity! Ten years of dedicated work, innovation, and achievements that have established us as a leader in the field of information systems development for the pharmaceutical industry.
Over this time, IRIS Soft has become a trusted partner for pharmaceutical companies. Our software solutions help ensure drug safety, optimize pharmacovigilance processes, and comply with the highest regulatory control standards.
We take pride in the fact that over the past 10 years, we have expanded the capabilities of our products, improved their functionality, and maintained a high level of customer service. Today, our solutions are used by leading companies in Ukraine and other countries, contributing to efficient data management and enhancing patient safety.
We sincerely thank our clients, partners, and our team of professionals who have made this journey possible! Your trust and collaboration are our main sources of inspiration. We are confident that many exciting opportunities, innovations, and achievements lie ahead!
We look forward to new challenges and further development in the next decade!
Best regards, The IRIS Soft Team
Other News
Development of a module to support GMP processes and pass production audits
We are pleased to announce that we have completed the development of a new software module “Register of Pharmaceutical Production Equipment and Systems DSBase-PER” to support GMP processes and production audits. The DSBase-PER module, through digitalization, improves the quality of management of accounting, operation, maintenance and repair processes of production equipment and enterprise systems, allows […]
Database on pharmacovigilance and safety of medicinal products DSBase has received new functionality
The Computerized system “Database on pharmacovigilance and safety of medicinal products DSBase” has received new functionality – the ability to import and export reports on adverse reactions or lack of efficacy of drugs in electronic form in the ICH E2B (R3) format, a format that is currently a standard in the EU. The International Conference […]